U.S. markets closed

XpresSpa Group, Inc. (XSPA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6700+0.1100 (+7.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Head and Shoulders Bottom

Head and Shoulders Bottom

Previous Close1.5600
Open1.5200
Bid1.6400 x 3000
Ask1.6800 x 28000
Day's Range1.5100 - 1.6900
52 Week Range1.0300 - 5.6000
Volume3,295,657
Avg. Volume4,222,795
Market Cap175.868M
Beta (5Y Monthly)2.49
PE Ratio (TTM)N/A
EPS (TTM)-1.1950
Earnings DateMay 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • XpresSpa Group Set to Join Russell Microcap® Index
    GlobeNewswire

    XpresSpa Group Set to Join Russell Microcap® Index

    NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution according to a preliminary list of additions posted on June 4. Joining the index would become effective after the US market opens on June 28. Membership in the Russell Microcap® Index, which remains in place for on

  • XpresSpa Group Announces the Launch of treatcare.com, Phase One of New Travel, Health and Wellness Lifestyle Brand
    GlobeNewswire

    XpresSpa Group Announces the Launch of treatcare.com, Phase One of New Travel, Health and Wellness Lifestyle Brand

    Treat™ aims to connect travelers with integrated care services so they can explore the world with confidenceInitial website and brand campaign launching todayMobile app launch (Phase Two) and first two locations (Phase Three) expected to open late Summer / early Fall NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced the launch of Treat™, a new travel brand that provides access to integrated care services that can seamlessly fit into a health and wellness lifestyle. Empowering travelers to take a health-first approach to the journey ahead, Treat will act as a wellness concierge, providing medical care and wellness services to consumers as they return to travel. “We are elated to announce the launch of Treat, our new lifestyle brand designed to accompany travelers wherever in the world they may go. With a focus on life-long wellness, we look forward to providing our members with an unencumbered confidence to travel, thanks to the knowledge that they have constant medical and wellness support at their fingertips,” said Doug Satzman, XpresSpa CEO. “Treat is positioned for a post-pandemic world and designed to deliver on-demand access to integrated healthcare through technology and personalized services. Travelers will be able to access health care, records and real-time information all in one place, as well as book appointments in our on-site airport wellness centers as they open.” Launching today, the Treat website (www.treatcare.com) will feature original content, access to resources about global COVID-19 requirements, and curated e-commerce. Memberships, available later this summer, will provide a mobile app subscription with access to integrated medical and wellness care, virtually and physically in select airports. Treat’s mobile app, launching later this summer, will provide access to on-demand virtual care, including chat care, video care and a “travel wallet” with access to a person’s medical records and test results. Treat in-airport Wellness Centers will offer services such as COVID-19 testing, travel vaccines, anxiety care, emergency prescriptions, vitamin IV therapies, as well as virtual wellness coaching, yoga and mindfulness sessions. Treat Wellness Centers will include a highly curated assortment of premium health and wellness travel items in their retail collection, with an expanded collection of the brands and products on the Treat website. The first two locations are expected to open in the late Summer / early Fall. About XpresSpa Group, Inc. XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company operating three distinct brands: Treat™, XpresCheck™, and XpresSpa™. Treat is a travel health and wellness company that provides on-demand access to healthcare through technology and personalized services. XpresCheck is a leading on-site airport provider of COVID-19 screening and testing with 13 locations in 11 domestic airports. XpresSpa is a leading airport retailer of spa services and related health and wellness products, with 45 locations in 23 airports globally. To learn more about XpresSpa Group, visit: www.XpresSpaGroup.com.To learn more about Treat, visit: www.TreatCare.com.To learn more about XpresCheck, visit: www.XpresCheck.com. Twitter: @Treat_Care and Instagram: @treat_careTwitter: @xprescheck and Instagram: @realxprescheckTwitter: @XpresSpa and Instagram: @XpresSpa Investor Relations:ICRRaphael Grossir@xpresspagroup.com(203) 682-8253 Media:Julie FergusonJulie@jfprmedia.com(312) 385-0098

  • Strong Earnings Confirm the Bull Thesis on XpresSpa  Stock, Says Analyst
    TipRanks

    Strong Earnings Confirm the Bull Thesis on XpresSpa Stock, Says Analyst

    XpresSpa (XSPA) made an unlikely move during the pandemic and turned its shuttered airport wellness business into Covid-19 testing facilities. Looking at the company’s 1Q21 results, H.C. Wainwright’s Scott Buck thinks the move has paid off. The company delivered revenue of $8.5 million, way above Buck’s forecast for revenue of $2.4 million. “The beat to our estimate reflects better than expected revenue contribution from XpresCheck, which totaled $8.2M, though included $3.2M in revenue that was unable to be recognized in prior quarters.” The result of which was also a big mark up for store margin, which came in at 51.1%, far above Buck’s 14.5% estimate, and also much higher than the pre-pandemic store margins of 21% and 22% in 2018 and 2019, respectively. What this proves to Buck is that the company’s XpresCheck initiative – the Covid-19 testing facilities – is providing “proof of concept to investors who have been less than patient in awaiting results.” There’s other good news. The company saw out the quarter operating 13 XpresCheck locations in 11 airports, six of which opened during the quarter, which implies to Buck that the full revenue contribution from all 13 locations is still to come. Furthermore, at last, the company revealed its new travel, health, and wellness brand, Treat. By the end of June, the company will start to roll out the latest concept, which will include some medical services as well as retail and travel products and services, in three phases. While there will initially be only two physical locations, Buck believes these “could potentially find homes” in as many as 30 U.S. airports. The physical stores will go alongside a meaningful digital footprint, which could provide a big opportunity for future growth. As such, Buck recommends investors “accumulate a position in XSPA shares ahead of what we anticipate to be a meaningful improvement in operating results.” All in all, Buck reiterated a Buy rating on XSPA stock along with a $3.5 price target. The implication for investors? Upside of 167%. (To watch Buck’s track record, click here) Some companies fly under Wall Street’s radar and XpresSpa currently appears to be one such name. Buck says the quarter’s results are “likely to open some eyes,” but the 5-star analyst’s review is currently the only one on record. (See XSPA stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.